DEGHOR 80MG INJ
Prescription Required
Sale price
₹ 7,800.00
Regular price
MRP: ₹ 13,447.97
42% OFF
Inclusive of all taxes.
Couldn't load pickup availability
DEGHOR 80MG INJ
Regular price
₹ 7,800.00
Regular price
₹ 13,447.97
Sale price
₹ 7,800.00
(-42%)
Unit price
per
DEGHOR 80MG INJ
Sale price
₹ 7,800.00
Regular price
MRP: ₹ 13,447.97
42% OFF
- Introduction
- Uses
- Storage
- Safety
- Side effects
- Abouts RareMeds
- Disclaimer
Introduction
Deghor 80mg Injection contains degarelix, a gonadotropin-releasing hormone (GnRH) receptor antagonist that rapidly reduces testosterone production.
Uses
Deghor 80mg Injection is used for the treatment of advanced hormone-dependent prostate cancer in adult men.
Storage
- Store refrigerated at 2°C–8°C.
- Reconstituted solution should be administered immediately as recommended.
Safety Information
- Monitor testosterone and prostate-specific antigen (PSA) levels during treatment.
- Inform your doctor about heart disease or liver disease before use.
Possible Side Effects
Possible side effects may include:
- Injection site reactions
- Hot flushes
- Weight gain
- Fatigue
- Increased liver enzymes
- Decreased libido
About RareMeds
We, at RareMeds, make a diligent attempt to deliver accurate, expert-drafted and thoroughly reviewed medicine-related information to our consumers. However, it should, by no means, be considered a substitute for a prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact, we detest any form of self-medication without expert advice.
The sole purpose of the information on our portal is to educate our consumers, which helps improve communication between a doctor and a patient. The information is by no means complete in its entirety and should not be used to diagnose or treat any medical condition.
No amount of information can replace the experience and expertise of a doctor; therefore, his/her advice always holds priority and should be followed appropriately.
Disclaimer
Deghor is a prescription anticancer medicine.
It should only be administered under the supervision of a qualified oncologist.